These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Jersey
|
22-1441806
|
|
(State of incorporation)
|
(IRS Employer Identification Number)
|
|
One Branca Road
East Rutherford, New Jersey
|
07073
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Title of Each Class
|
Name of Exchange on Which Registered
|
|
Common Stock $.10 par value
|
NYSE Amex
|
|
PART I.
|
Page
|
|
|
Item 1.
|
4 | |
|
Item 1A.
|
9 | |
|
Item 2.
|
9 | |
|
Item 3.
|
10 | |
|
Item 4.
|
10 | |
|
PART II.
|
||
|
Item 5.
|
11 | |
|
Item 6.
|
12 | |
|
Item 7.
|
13 | |
|
Item 7A.
|
18 | |
|
Item 8.
|
19 | |
|
Item 9.
|
50 | |
|
Item 9A.
|
50 | |
|
Item 9B.
|
50 | |
|
PART III.
|
||
|
Item 10.
|
51 | |
|
Item 11.
|
53 | |
|
Item 12.
|
56 | |
|
Item 13.
|
58 | |
|
Item 14.
|
59 | |
|
PART IV
|
||
|
Item 15.
|
60 | |
| 62 |
|
Commercial
|
Government
|
Total
|
||||||||||
|
March 31, 2013
|
$
|
388,941
|
$
|
35,974,074
|
$
|
36,363,015
|
||||||
|
March 31, 2012
|
$
|
229,530
|
$
|
39,131,357
|
$
|
39,360,887
|
||||||
|
Fiscal Year
|
||||||||
|
Ended March 31,
|
||||||||
|
2013
|
High
|
Low
|
||||||
|
First Quarter
|
$
|
6.35
|
$
|
3.40
|
||||
|
Second Quarter
|
4.27
|
3.25
|
||||||
|
Third Quarter
|
3.95
|
3.42
|
||||||
|
Fourth Quarter
|
3.87
|
3.22
|
||||||
|
2012
|
||||||||
|
First Quarter
|
$
|
9.23
|
$
|
7.03
|
||||
|
Second Quarter
|
9.18
|
7.60
|
||||||
|
Third Quarter
|
7.99
|
6.05
|
||||||
|
Fourth Quarter
|
7.92
|
6.04
|
||||||
|
Plan category
|
Number of securities to be issued upon exercise of outstanding options
|
Weighted average exercise price of outstanding options
|
Number of options remaining available for future issuance under Equity Compensation Plans
|
|||||||||
|
Equity Compensation Plans approved by shareholders
|
114,600
|
$
|
5.53
|
218,978
|
||||||||
|
Equity Compensation Plans not approved by shareholders
|
--
|
--
|
--
|
|||||||||
|
Total
|
114,600
|
$
|
5.53
|
218,978
|
||||||||
|
Pages
|
|
|
(1) Financial Statements:
|
|
| 20 | |
| 21 | |
| 22 | |
| 23 | |
| 24 | |
| 25-48 | |
|
(2) Financial Statement Schedule:
|
|
| 49 |
|
ASSETS
|
March 31, 2013
|
March 31, 2012
|
||||||
|
Current assets:
|
||||||||
|
Cash
|
$
|
310,297
|
$
|
413,195
|
||||
|
Accounts receivable, net of allowance for doubtful accounts
of $18,940 and $35,470, respectively
|
557,879
|
1,694,636
|
||||||
|
Unbilled government receivables
|
-
|
1,780,381
|
||||||
|
Inventories, net
|
6,241,181
|
5,023,975
|
||||||
|
Prepaid expenses and other current assets
|
115,852
|
220,255
|
||||||
|
Deferred financing costs
|
108,321
|
108,321
|
||||||
|
Deferred tax asset
|
1,238,421
|
1,288,631
|
||||||
|
Total current assets
|
8,571,951
|
10,529,394
|
||||||
|
Equipment and leasehold improvements, net
|
587,958
|
706,870
|
||||||
|
Deferred financing costs – long-term
|
156,463
|
264,784
|
||||||
|
Deferred tax asset – non-current
|
2,546,190
|
948,489
|
||||||
|
Other assets
|
56,872
|
56,872
|
||||||
|
Total assets
|
$
|
11,919,434
|
$
|
12,506,409
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Current portion of long-term debt
|
$
|
1,229,643
|
$
|
542,382
|
||||
|
Capital lease obligations – current portion
|
74,508
|
64,675
|
||||||
|
Accounts payable
|
4,272,431
|
2,850,432
|
||||||
|
Deferred revenues – current portion
|
18,460
|
34,767
|
||||||
|
Accrued expenses - vacation pay, payroll and payroll withholdings
|
442,522
|
440,116
|
||||||
|
Accrued expenses - related parties
|
100,536
|
68,777
|
||||||
|
Accrued expenses – other
|
1,425,002
|
2,006,134
|
||||||
|
Total current liabilities
|
7,563,102
|
6,007,283
|
||||||
|
Subordinated notes payable – related parties
|
250,000
|
250,000
|
||||||
|
Capital lease obligations – long-term
|
76,055
|
149,582
|
||||||
|
Long-term debt, net of debt discount
|
1,134,549
|
1,490,302
|
||||||
|
Warrant liability
|
198,330
|
355,290
|
||||||
|
Deferred revenues – long-term
|
1,045
|
4,637
|
||||||
|
Total liabilities
|
9,223,081
|
8,257,094
|
||||||
|
Commitments and contingencies
|
||||||||
|
Stockholders’ equity
|
||||||||
|
Common stock, 4,000,000 shares authorized, par value $.10 per share,
3,011,739 and 2,684,215 shares issued and outstanding, respectively
|
301,171
|
268,421
|
||||||
|
Additional paid-in capital
|
7,108,300
|
5,921,441
|
||||||
|
Accumulated deficit
|
(4,713,118
|
)
|
(1,940,547
|
)
|
||||
|
Total stockholders’ equity
|
2,696,353
|
4,249,315
|
||||||
|
Total liabilities and stockholders’ equity
|
$
|
11,919,434
|
$
|
12,506,409
|
||||
|
For the years ended March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Net sales
|
$
|
7,827,258
|
$
|
16,508,678
|
||||
|
Cost of sales
|
6,866,036
|
10,068,236
|
||||||
|
Gross margin
|
961,222
|
6,440,442
|
||||||
|
Operating expenses:
|
||||||||
|
Selling, general and administrative
|
2,564,637
|
2,969,956
|
||||||
|
Engineering, research and development
|
2,149,591
|
2,794,478
|
||||||
|
Total operating expenses
|
4,714,228
|
5,764,434
|
||||||
|
(Loss) income from operations
|
(3,753,006
|
)
|
676,008
|
|||||
|
Other income (expense):
|
||||||||
|
Amortization of debt discount
|
(129,763
|
)
|
(53,570
|
)
|
||||
|
Amortization of deferred financing costs
|
(219,662
|
)
|
(108,321
|
)
|
||||
|
Change in fair value of common stock warrants
|
294,785
|
10,847
|
||||||
|
Gain on sales of capital asset
|
-
|
500
|
||||||
|
Proceeds from life insurance policy
|
-
|
300,029
|
||||||
|
Interest income
|
434
|
616
|
||||||
|
Interest expense
|
(478,939
|
)
|
(367,410
|
)
|
||||
|
Interest expense - related parties
|
(30,000
|
)
|
(31,964
|
)
|
||||
|
Total other expense
|
(563,145
|
)
|
(249,273
|
)
|
||||
|
(Loss) income before income taxes
|
(4,316,151
|
)
|
426,735
|
|||||
|
(Benefit) provision for income taxes
|
(1,543,580
|
)
|
355,719
|
|||||
|
Net (loss) income
|
$
|
(2,772,571
|
)
|
$
|
71,016
|
|||
|
Basic (loss) income per common share
|
$
|
(0.98
|
)
|
$
|
0.03
|
|||
|
Diluted (loss) income per common share
|
$
|
(0.98
|
)
|
$
|
0.02
|
|||
|
Weighted average number of shares outstanding
|
||||||||
|
Basic
|
2,834,257
|
2,657,279
|
||||||
|
Diluted
|
2,834,257
|
2,717,820
|
||||||
|
Common Stock
|
Additional
|
|||||||||||||||||||
|
# of Shares
Issued
|
Amount
|
Paid-In
Capital
|
Accumulated
Deficit
|
Total
|
||||||||||||||||
|
Balances at April 1, 2011
|
2,646,215
|
264,621
|
5,711,531
|
(2,011,563
|
)
|
3,964,589
|
||||||||||||||
|
Net income
|
-
|
-
|
71,016
|
71,016
|
||||||||||||||||
|
Stock-based compensation
|
-
|
-
|
89,079
|
-
|
89,079
|
|||||||||||||||
|
Issuance of common stock in connection with the exercise of stock options
|
38,000
|
3,800
|
120,831
|
-
|
124,631
|
|||||||||||||||
|
Balances at March 31, 2012
|
2,684,215
|
$
|
268,421
|
$
|
5,921,441
|
$
|
(1,940,547
|
)
|
$
|
4,249,315
|
||||||||||
|
Stock-based compensation
|
-
|
-
|
81,517
|
-
|
81,517
|
|||||||||||||||
|
Net loss
|
-
|
-
|
-
|
(2,772,571
|
)
|
(2,772,571
|
)
|
|||||||||||||
|
Issuance of new shares in connection with stock subscription agreements
|
288,424
|
28,840
|
971,162
|
-
|
1,000,002
|
|||||||||||||||
|
Issuance of common stock in connection with the exercise of stock options
|
39,100
|
3,910
|
134,180
|
-
|
138,090
|
|||||||||||||||
|
Balances at March 31, 2013
|
3,011,739
|
$
|
301,171
|
$
|
7,108,300
|
$
|
(4,713,118
|
)
|
$
|
2,696,353
|
||||||||||
|
For the years ended March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net (loss) income
|
$
|
(2,772,571
|
)
|
$
|
71,016
|
|||
|
Adjustments to reconcile net (loss) income to net cash
(Used in) provided by operating activities:
|
||||||||
|
Deferred income taxes
|
(1,547,491
|
)
|
352,219
|
|||||
|
Allowance for doubtful accounts
|
(16,530
|
)
|
(1,200
|
)
|
||||
|
Depreciation and amortization
|
228,069
|
168,667
|
||||||
|
Amortization of debt discount
|
129,763
|
53,570
|
||||||
|
Amortization of deferred financing costs
|
219,662
|
108,321
|
||||||
|
Change in fair value of common stock warrant
|
(294,785
|
)
|
(10,847
|
)
|
||||
|
Provision for inventory obsolescence
|
-
|
21,972
|
||||||
|
Proceeds from life insurance policy
|
-
|
(300,029
|
)
|
|||||
|
Gain on sale of asset
|
-
|
(500
|
)
|
|||||
|
Increase in cash surrender value of life insurance
|
-
|
2,011
|
||||||
|
Stock-based compensation
|
81,517
|
89,079
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Decrease in accounts receivable
|
1,153,287
|
892,183
|
||||||
|
Decrease (increase) in unbilled government receivables
|
1,780,381
|
(313,758
|
)
|
|||||
|
Increase in inventories
|
(1,217,206
|
)
|
(2,075,569
|
)
|
||||
|
Dncrease (increase) in prepaid expenses and other
|
104,403
|
(182,087
|
)
|
|||||
|
Increase in accounts payable
|
1,421,999
|
1,251,753
|
||||||
|
Decrease in deferred revenues
|
(19,899
|
)
|
(4,359
|
)
|
||||
|
Increase (decrease) in accrued payroll, vacation pay & withholdings
|
2,406
|
(5,622
|
)
|
|||||
|
Increase (decrease) in accrued expenses – related party and other
|
(549,373
|
)
|
787,877
|
|||||
|
(Decrease) increase in progress billings
|
-
|
(424,202
|
)
|
|||||
|
Net cash provided by (used in) operating activities
|
(1,296,368
|
)
|
480,495
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Proceeds from sale of capital asset
|
-
|
500
|
||||||
|
Acquisition of equipment
|
(109,157
|
)
|
(300,857
|
)
|
||||
|
Net cash used in investing activities
|
(109,157
|
)
|
(300,357
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from exercise of stock options
|
138,090
|
124,631
|
||||||
|
Proceeds from the issuance of new shares of common stock
|
1,000,002
|
-
|
||||||
|
Proceeds from issuance of debt
|
600,000
|
-
|
||||||
|
Expenses associated with long-term debt
|
(111,341
|
)
|
-
|
|||||
|
Repayment of long-term debt
|
(260,430
|
)
|
(282,798
|
)
|
||||
|
Repayment of capitalized lease obligations
|
(63,694
|
)
|
(45,414
|
)
|
||||
|
Proceeds from life insurance policy
|
-
|
312,683
|
||||||
|
Net cash provided by financing activities
|
1,302,627
|
109,102
|
||||||
|
Net (decrease) increase in cash
|
(102,898
|
)
|
289,240
|
|||||
|
Cash, beginning of year
|
413,195
|
123,955
|
||||||
|
Cash, end of year
|
$
|
310,297
|
$
|
413,195
|
||||
|
Supplemental cash flow information:
|
||||||||
|
Taxes paid
|
$
|
-
|
$
|
1,542
|
||||
|
Interest paid
|
$
|
368,188
|
$
|
359,248
|
||||
|
Supplemental non-cash information
|
||||||||
|
Warrants issued in conjunction with long-term debt
|
$
|
66,193
|
$
|
-
|
||||
|
Warants issued to lender for waiver of debt covenants
|
$
|
71,632
|
$
|
-
|
||||
|
Capitalized lease obligations
|
$
|
-
|
$
|
243,986
|
||||
|
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Government
|
$
|
423,165
|
$
|
1,272,436
|
||||
|
Commercial
|
153,654
|
457,670
|
||||||
|
Less: Allowance for doubtful accounts
|
(18,940
|
)
|
(35,470
|
)
|
||||
|
$
|
557,879
|
$
|
1,694,636
|
|||||
|
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Purchased parts
|
$
|
4,418,989
|
$
|
3,452,832
|
||||
|
Work-in-process
|
1,636,325
|
1,725,395
|
||||||
|
Finished goods
|
385,867
|
45,748
|
||||||
|
Less: Allowance for obsolete inventory
|
(200,000
|
)
|
(200,000
|
)
|
||||
|
$
|
6,241,181
|
$
|
5,023,975
|
|||||
|
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Leasehold Improvements
|
$
|
94,413
|
$
|
92,663
|
||||
|
Machinery and equipment
|
1,474,192
|
1,407,096
|
||||||
|
Automobiles
|
4,741
|
4,741
|
||||||
|
Sales equipment
|
591,109
|
561,571
|
||||||
|
Assets under capitalized leases
|
610,995
|
610,995
|
||||||
|
Less: Accumulated depreciation & amortization
|
(2,187,492
|
)
|
(1,970,196
|
)
|
||||
|
$
|
587,958
|
$
|
706,870
|
|||||
|
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Accrued vacation pay
|
$
|
273,612
|
$
|
269,490
|
||||
|
Accrued payroll and payroll withholdings
|
168,910
|
170,626
|
||||||
|
$
|
442,522
|
$
|
440,116
|
|||||
|
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Accrued interest
|
$
|
110,751
|
$
|
-
|
||||
|
Accrued outside contractor costs
|
882,351
|
1,178,232
|
||||||
|
Accrued commissions
|
8,448
|
148,731
|
||||||
|
Warranty Reserve
|
287,470
|
271,629
|
||||||
|
Accrued – other
|
135,982
|
407,542
|
||||||
|
$
|
1,425,002
|
$
|
2,006,134
|
|||||
|
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Interest due to the estate
of the Company’s former Chairman
|
$
|
46,518
|
$
|
31,518
|
||||
|
Interest and other expenses due to
the Company’s President/CEO
|
54,018
|
37,259
|
||||||
|
$
|
100,536
|
$
|
68,777
|
|||||
|
Fiscal Year Ended
|
||||||||
|
March 31,
|
March 31,
|
|||||||
|
2013
|
2012
|
|||||||
|
Current:
|
||||||||
|
Federal
|
$
|
-
|
$
|
-
|
||||
|
State and local
|
3,911
|
3,500
|
||||||
|
Total current tax provision
|
3,911
|
3,500
|
||||||
|
Deferred:
|
||||||||
|
Federal
|
(1,561,076)
|
(32,698
|
)
|
|||||
|
State and local
|
13,585
|
384,917
|
||||||
|
|
||||||||
|
Total deferred tax (benefit) provision
|
(1,547,491
|
)
|
352,219
|
|||||
|
Total (benefit) provision
|
$
|
(1,543,580
|
)
|
$
|
355,719
|
|||
|
March 31,
|
March 31,
|
|||||||
|
2013
|
2012
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Net operating loss carryforwards
|
$
|
3,086,000
|
$
|
1,761,000
|
||||
|
Tax credits
|
279,000
|
239,000
|
||||||
|
Allowance for doubtful accounts
|
7,000
|
13,000
|
||||||
|
Reserve for inventory obsolescence
|
69,000
|
72,000
|
||||||
|
Inventory capitalization
|
183,000
|
92,000
|
||||||
|
Deferred payroll and accrued interest
|
-
|
16,000
|
||||||
|
Vacation accrual
|
95,000
|
96,000
|
||||||
|
Warranty reserve
|
100,000
|
97,000
|
||||||
|
Deferred revenues
|
2,000
|
9,000
|
||||||
|
Stock options
|
32,000
|
29,000
|
||||||
|
Non-compete agreement
|
14,000
|
17,000
|
||||||
|
Depreciation
|
(82,000
|
)
|
(154,000
|
)
|
||||
|
Deferred tax asset
|
3,785,000
|
2,287,000
|
||||||
|
Less valuation allowance
|
1,000
|
50,000
|
||||||
|
Deferred tax asset, net
|
$
|
3,784,000
|
$
|
2,237,000
|
||||
|
Deferred tax asset – current
|
$
|
1,238,000
|
$
|
1,289,000
|
||||
|
Deferred tax asset – long-term
|
2,546,000
|
948,000
|
||||||
|
Total
|
$
|
3,784,000
|
$
|
2,237,000
|
||||
|
March 31,
|
March 31,
|
|||||||
|
2013
|
2012
|
|||||||
|
Income tax (benefit) provision – statutory rate
|
$
|
(1,467,491
|
)
|
$
|
145,088
|
|||
|
Income tax expenses – state and local, net of federal benefit
|
3,500
|
256,355
|
||||||
|
Permanent items
|
(38,350
|
)
|
(82,578
|
)
|
||||
|
Research credits
|
-
|
(18,057
|
)
|
|||||
|
True-up of prior years deferred taxes
|
(67,246
|
)
|
57,277
|
|||||
|
Change in state rate
|
85,945
|
-
|
||||||
|
Change in valuation allowance
|
(49,718
|
)
|
||||||
|
Other
|
(10,220
|
)
|
(2,366
|
)
|
||||
|
Income tax (benefit) provision
|
$
|
(1,543,580
|
)
|
$
|
355,719
|
|||
|
1.
|
The Note has a term of five (5) years with an annual interest rate of 14% on the outstanding principal amount. Payments for the first year are interest only and amounted to $28,762 monthly. In September 2011, the Company began making monthly payments of approximately $69,000 for interest and principal for the remaining term of the loan. BCA had agreed to allow the Company to defer principal payments for the three months ended September 30, 2012. BCA has also agreed to allow the Company to defer principal payments due on October 31 and November 30, 2012. These amounts are deferred until September 2015. BCA has also agreed to allow the Company to defer principal payments due on December 31, 2012 and January 31, 2013 to February 2013, at which time the Company paid these deferred principal payments
|
|
|
|
|
2.
|
At inception, the Company issued BCA a nine-year warrant for 136,090 shares, based upon 4.5% of the fully –diluted outstanding shares of the Company’s common stock at $6.70 per share, the average closing price over the three days preceding the loan closing on the NYSE-MKT Exchange. In the event of specific major corporate events or the maturity of the five-year loan, BCA can require the Company to purchase the warrant and warrant shares at the higher of the then Exchange market price less the share exercise price, in the case of the warrant, or five times operating income per share. In connection with the warrant issued in conjunction with this debt, the Company recorded a debt discount (see above) and warrant liability, which is marked to fair value at the end of each period (see Note 18 to Notes to the Consolidated Financial Statements). The debt discount is being amortized over the life of the loan.
|
|
|
|
|
3.
|
Loan provisions also contain customary representations and warranties.
|
|
|
|
|
4.
|
BCA has a lien on all of the Company’s assets. In February 2011, BCA agreed to release part of its lien on Company assets to the U.S. Government to allow for progress billings up to $1,000,000.
|
|
|
|
|
5.
|
The Company was required to pay prepayment fees if the Company decided to prepay a portion of the principal amount during the first two years of the loan. The Company may now prepay a portion of the principal amount without any prepayment penalty. Each payment must be not less than $25,000 or multiples of $25,000 in excess thereof.
|
|
|
|
|
6.
|
Upon the occurrence of a Change of Control or within five (5) Business Days of an O’Hara Life Insurance Realization Event, the Company shall, in each case at the election of BCA, prepay by wire transfer the entire outstanding principal amount of the Note in accordance with the redemption prices (the “Mandatory Redemption Prices”) set forth below (expressed as a percentage of the outstanding principal amount being prepaid and shall pay 103% in the first loan year, 102% in the second loan year, and 100% thereafter), together with (x) Interest, if any, accrued and unpaid on the outstanding principal amount of the Note so prepaid through the date of such prepayment, (y) all reasonable out-of-pocket costs and expenses (including reasonable fees, charges and disbursements of counsel), if any, associated with such prepayment, and (z) all other costs, expenses and indemnities then payable under this Agreement (such amounts, collectively the “Mandatory Redemption Payment”). If a Change of Control or O’Hara Life Insurance Realization Event shall occur during any Loan Year set forth below, the Mandatory Redemption Price shall be determined based upon the percentage indicated above for such Loan Year multiplied by the principal amount which is being prepaid. At the election of BCA, all or any portion of the Mandatory Redemption Payment may be paid in the form of Marketable Securities in lieu of cash and to the extent available and to the extent not restricted by any SBIC Regulations. In the event BCA makes the election contemplated by the immediately preceding sentence, the Issuer shall issue to Purchaser that number of shares having an aggregate Current Market Price as of such issuance date equal to that portion of the Mandatory Redemption Payment subject to such election.
|
|
7.
|
The BCA notes contain a number of affirmative and negative covenants which could restrict our operations. For the quarter ended March 31, 2013, the Company was not in compliance with four covenants related to EBITDA and maintaining agreed upon financial ratios for fixed charges, total leverage and debt service. In consideration for the waiver for non-compliance of the financial covenants as of March 31, 2013 and for the deferral of principal payments, BCA received warrants to purchase 20,000 shares of the Company’s common stock. The common stock underlying the warrant is exercisable at a price of $3.33 per share and the warrants expire on September 10, 2019.
|
|
8.
|
The Company and BCA have amended certain provisions to ease some restrictions, including non-compliance with financial covenants, deferral of principal payments, and approval to obtain progress payments from the government.
|
|
2014
|
$
|
1,229,643
|
||
|
2015
|
673,486
|
|||
|
2016
|
678,643
|
|||
|
2017
|
-
|
|||
|
Total
|
$
|
2,581,772
|
|
Years Ended March 31,
|
||||
|
2014
|
$
|
269,853
|
||
|
2015
|
258,518
|
|||
|
2016
|
254,840
|
|||
|
2017
|
84,947
|
|||
|
2018
|
--
|
|||
|
$
|
868,158
|
|||
|
2014
|
$
|
91,335
|
||
|
2015
|
59,592
|
|||
|
2016
|
18,685
|
|||
|
2017
|
4,670
|
|||
|
2018
|
--
|
|||
|
Total minimum lease payments
|
174,282
|
|||
|
Less amounts representing interest
|
(23,719
|
)
|
||
|
Present value of net minimum lease payments
|
150,563
|
|||
|
Less current portion
|
(74,508
|
)
|
||
|
Long-term capital lease obligation
|
$
|
76,055
|
|
2013
|
2012
|
|||||||
|
United States
|
$
|
6,893,832
|
$
|
14,776,451
|
||||
|
Foreign countries
|
933,426
|
1,732,227
|
||||||
|
Total
|
$
|
7,827,258
|
$
|
16,508,678
|
||||
|
Year
|
Dividend Yield
|
Risk-free Interest rate
|
Volatility
|
Life
|
||||||||||||
|
2013
|
0.0
|
%
|
|
0.79
%
|
|
45.3
%
|
5 years
|
|||||||||
|
2012
|
0.0
|
%
|
0.86%
|
- |
1.08%
|
36.07%
|
- |
36.63%
|
5 years
|
|||||||
|
Number of Options
|
Average Exercise Price
|
Average Remaining
Contractual Term
|
Aggregate Intrinsic
Value
|
||||||||||
|
Outstanding options at April 1, 2011
|
248,850
|
$
|
4.69
|
||||||||||
|
Options granted
|
18,000
|
$
|
7.28
|
||||||||||
|
Options exercised
|
(38,000
|
)
|
$
|
3.28
|
|||||||||
|
Options canceled/forfeited
|
(27,750
|
)
|
$
|
5.04
|
|||||||||
|
Outstanding options at March 31, 2012
|
201,100
|
$
|
5.14
|
2.1 years
|
$
|
321,114
|
|||||||
|
Options granted
|
10,000
|
$
|
3.50
|
||||||||||
|
Options exercised
|
(39,100
|
)
|
$
|
3.53
|
|||||||||
|
Options canceled/forfeited
|
(57,400
|
)
|
$
|
5.17
|
|||||||||
|
Outstanding options at March 31, 2013
|
114,600
|
$
|
5.53
|
2.0 years
|
$
|
-0-
|
|||||||
|
Vested Options:
|
|||||||||||||
|
March 31, 2013:
|
71,100
|
$
|
4.29
|
1.4 years
|
$
|
-0-
|
|||||||
|
March 31, 2012:
|
119,760
|
$
|
4.29
|
1.3 years
|
$
|
263,099
|
|||||||
|
Non-vested Shares
|
Shares
|
Weighted-Average
Grant-Date
Fair value
|
||||||
|
Non-vested at April 1, 2012
|
81,340
|
$
|
6.40
|
|||||
|
Granted
|
10,000
|
$
|
3.50
|
|||||
|
Vested
|
(28,200
|
)
|
$
|
5.11
|
||||
|
Forfeited
|
(19,640
|
)
|
$
|
7.24
|
||||
|
Non-vested at March 31, 2013
|
43,500
|
$
|
6.25
|
|||||
|
March 31, 2013
|
March 31, 2012
|
|||||||
|
Basic net (loss) income per share computation:
|
||||||||
|
Net (loss) income
|
$
|
(2,772,571
|
)
|
$
|
71,016
|
|||
|
Weighted-average common shares outstanding
|
2,834,257
|
2,657,279
|
||||||
|
Basic net (loss) income per share
|
$
|
(0.98
|
)
|
$
|
0.03
|
|||
|
Diluted net (loss) income per share computation
|
||||||||
|
Net (loss) income
|
$
|
(2,772,571
|
)
|
$
|
60,169
|
(1) | ||
|
Weighted-average common shares outstanding
|
2,834,257
|
2,657,279
|
||||||
|
Incremental shares attributable to the assumed exercise of
outstanding stock options and warrants
|
-
|
60,541
|
||||||
|
Total adjusted weighted-average shares
|
2,834,257
|
2,717,820
|
||||||
|
Diluted net (loss) income per share
|
$
|
(0.98
|
)
|
$
|
0.02
|
|||
|
2013
|
Avionics
Government
|
Avionics
Commercial
|
Avionics
Total
|
Corporate/
Reconciling Items
|
Total
|
|||||||||||||||
|
Net sales
|
$
|
5,779,947
|
$
|
2,047,311
|
$
|
7,827,258
|
$
|
-
|
$
|
7,827,258
|
||||||||||
|
Cost of Sales
|
4,934,322
|
1,931,714
|
6,866,036
|
-
|
6,866,036
|
|||||||||||||||
|
Gross Margin
|
845,625
|
115,597
|
961,222
|
-
|
961,222
|
|||||||||||||||
|
Engineering, research, and
development
|
2,149,591
|
2,149,591
|
||||||||||||||||||
|
Selling, general, and admin.
|
1,162,608
|
1,402,029
|
2,564,637
|
|||||||||||||||||
|
Amortization of debt discount
|
-
|
129,763
|
129,763
|
|||||||||||||||||
|
Amortization of deferred financing costs
|
-
|
219,662
|
219,662
|
|||||||||||||||||
|
Change in fair value of
common stock warrant
|
-
|
(294,785
|
)
|
(294,785
|
)
|
|||||||||||||||
|
Interest expense, net
|
-
|
508,505
|
508,505
|
|||||||||||||||||
|
3,312,199
|
1,965,174
|
5,277,373
|
||||||||||||||||||
|
(Loss) income before income taxes
|
$
|
(2,350,977
|
)
|
$
|
(1,965,174
|
)
|
$
|
(4,316,151
|
)
|
|||||||||||
|
Segment Assets
|
$
|
5,191,777
|
$
|
1,651,204
|
$
|
6,848,981
|
$
|
5,070,453
|
$
|
11,919,434
|
||||||||||
|
2012
|
Avionics
Government
|
Avionics
Commercial
|
Avionics
Total
|
Corporate/
Reconciling Items
|
Total
|
|||||||||||||||
|
Net sales
|
$
|
14,013,807
|
$
|
2,494,871
|
$
|
16,508,678
|
$
|
-
|
$
|
16,508,678
|
||||||||||
|
Cost of Sales
|
8,424,141
|
1,644,095
|
10,068,236
|
-
|
10,068,236
|
|||||||||||||||
|
Gross Margin
|
5,589,666
|
850,776
|
6,440,442
|
-
|
6,440,442
|
|||||||||||||||
|
Engineering, research, and
Development
|
2,794,478
|
2,794,478
|
||||||||||||||||||
|
Selling, general, and admin.
|
1,488,114
|
1,481,842
|
2,969,956
|
|||||||||||||||||
|
Amortization of debt discount
|
-
|
53,570
|
53,570
|
|||||||||||||||||
|
Amortization of deferred financing costs
|
-
|
108,321
|
108,321
|
|||||||||||||||||
| Proceeds from life insurance | - | (300,029) | (300,029) | |||||||||||||||||
|
Change in fair value of
common stock warrant
|
-
|
(10,847
|
)
|
(10,847
|
)
|
|||||||||||||||
|
Gain on sale of asset
|
-
|
(500
|
)
|
(500
|
)
|
|||||||||||||||
|
Interest expense, net
|
-
|
398,758
|
398,758
|
|||||||||||||||||
|
4,282,592
|
1,731,115
|
6,013,707
|
||||||||||||||||||
|
Income (loss) before income taxes
|
$
|
2,157,850
|
$
|
(1,731,115
|
)
|
$
|
426,735
|
|||||||||||||
|
Segment Assets
|
$
|
7,743,372
|
$
|
755,620
|
$
|
8,498,992
|
$
|
4,007,417
|
$
|
12,506,409
|
||||||||||
| FY 2013 | June 30 | September 30 | December 31 | March 31 | |||||||||||||
|
Net sales
|
$ | 1,177,288 | $ | 2,394,950 | $ | 2,350,020 | $ | 1,905,000 | |||||||||
|
Gross margin
|
283,694 | 602,423 | 453,368 | (378,263 | ) | (2) | |||||||||||
|
Loss before taxes
|
(832,344 | ) | (878,276 | ) | (848,965 | ) | (1,756,566 | ) | |||||||||
|
Net loss
|
(668,800 | ) | (429,705 | ) | (545,177 | ) | (1,128,889 | ) | |||||||||
|
Basic loss per share
|
(0.25 | ) | (0.16 | ) | (0.19 | ) | (0.38 | ) | |||||||||
|
Diluted loss per share
|
(0.25 | ) | (0.16 | ) | (0.19 | ) | (0.38 | ) | |||||||||
|
Quarter Ended
|
|||||||||||||||||
|
FY 2012
|
June 30
|
September 30
|
December 31
|
March 31
|
|||||||||||||
|
(restated)
|
|||||||||||||||||
|
Net sales
|
$
|
3,990,211
|
$
|
3,674,354
|
$
|
3,673,235
|
$
|
5,170,878
|
|||||||||
|
Gross margin
|
1,861,631
|
1,483,227
|
1,445,379
|
1,650,205
|
|||||||||||||
|
Income before taxes
|
202,138
|
105,220
|
75,142
|
44,235
|
|||||||||||||
|
Net income (loss) (1)
|
(80,795
|
)
|
103,316
|
97,431
|
(48,936
|
)
|
|||||||||||
|
Basic income (loss) per share (1)
|
(0.03
|
)
|
0.04
|
0.04
|
(0.02
|
)
|
|||||||||||
|
Diluted income (loss) per share (1)
|
(0.03
|
)
|
0.04
|
0.04
|
(0.02
|
)
|
|||||||||||
|
March 31, 2013
|
Level I
|
Level II
|
Level III
|
Total
|
||||||||||||
|
Warrant Liability
|
$ |
-
|
$ |
-
|
$ |
198,330
|
$ |
198,330
|
||||||||
|
Total Liabilities
|
$
|
-
|
$
|
-
|
$
|
198,330
|
$
|
198,330
|
||||||||
|
March 31, 2012
|
Level I
|
Level II
|
Level III
|
Total
|
||||||||||||
|
Warrant Liability
|
$ |
-
|
$ |
-
|
$ |
355,290
|
$ |
355,290
|
||||||||
|
Total Liabilities
|
$
|
-
|
$
|
-
|
$
|
355,290
|
$
|
355,290
|
||||||||
|
March 31, 2013
|
March 31, 2012
|
|||||||
|
Fair value, at beginning of period
|
$
|
355,290
|
$
|
366,137
|
||||
|
New issuances
|
137,825
|
-
|
||||||
|
Change in fair value
|
(294,785
|
)
|
(10,847
|
)
|
||||
|
Fair value, at end of period
|
$
|
198,330
|
$
|
355,290
|
||||
|
Date of
Warrant
|
Expiration
Date
|
Number of
Warrants
|
Exercise
Price
|
Fair Market Value
Per Share
|
Expected
Volatility
|
Remaining Life in Years
|
Risk Free
Interest Rate
|
Warrant
Liability
|
|||||||||||||||||||||||
| 09-10-2010 |
09-10-2019
|
136,920
|
$
|
6.70
|
$
|
6.70
|
28.51
|
%
|
9
|
2.81
|
%
|
$
|
267,848
|
||||||||||||||||||
| 09-10-2010 |
09-10-2015
|
10,416
|
$
|
6.70
|
$
|
6.70
|
28.51
|
%
|
5
|
1.59
|
%
|
$
|
13,808
|
||||||||||||||||||
| 07-26-2012 |
09-10-2019
|
50,000
|
$
|
3.35
|
$
|
3.90
|
42.04
|
%
|
7
|
0.94
|
%
|
$
|
66,193
|
||||||||||||||||||
| 07-26-2012 |
09-10-2019
|
20,000
|
$
|
3.35
|
$
|
3.90
|
42.04
|
%
|
7
|
0.94
|
%
|
$
|
26,477
|
||||||||||||||||||
| 11-20-2012 |
09-10-2019
|
20,000
|
$
|
3.56
|
$
|
3.50
|
42.45
|
%
|
6.83
|
1.09
|
%
|
21,441
|
|||||||||||||||||||
| 02-14-2013 |
09-10-2019
|
20,000
|
$
|
3.58
|
$
|
3.80
|
41.72
|
%
|
6.58
|
1.43
|
%
|
23,714
|
|||||||||||||||||||
|
Date of
Warrant
|
Expiration
Date
|
Number of
Warrants
|
Exercise
Price
|
Fair Market Value
Per Share
|
Expected
Volatility
|
Remaining
Life in Years
|
Risk Free
Interest Rate
|
Warrant
Liability
|
|||||||||||||||||||||||
| 09-10-2010 |
09-10-2019
|
136,920
|
$
|
6.70
|
$
|
6.33
|
53.19
|
%
|
7.45
|
2.23
|
%
|
$
|
338,116
|
||||||||||||||||||
| 09-10-2010 |
09-10-2015
|
10,416
|
$
|
6.70
|
$
|
6.33
|
53.19
|
%
|
3.45
|
2.23
|
%
|
$
|
17,174
|
||||||||||||||||||
|
Date of
Warrant
|
Expiration
Date
|
Number of
Warrants
|
Exercise
Price
|
Fair Market Value
Per Share
|
Expected
Volatility
|
Remaining
Life in Years
|
Risk Free
Interest Rate
|
Warrant
Liability
|
|||||||||||||||||||||||
| 09-10-2010 |
09-10-2019
|
136,920
|
$
|
6.70
|
$
|
3.50
|
41.45
|
%
|
6.45
|
1.24
|
%
|
$
|
81,080
|
||||||||||||||||||
| 09-10-2010 |
09-10-2015
|
10,416
|
$
|
6.70
|
$
|
3.50
|
41.45
|
%
|
2.45
|
0.25
|
%
|
$
|
1,870
|
||||||||||||||||||
| 07-26-2012 |
09-10-2019
|
50,000
|
$
|
3.35
|
$
|
3.50
|
41.45
|
%
|
6.33
|
1.24
|
%
|
$
|
53,269
|
||||||||||||||||||
| 07-26-2012 |
09-10-2019
|
20,000
|
$
|
3.35
|
$
|
3.50
|
41.45
|
%
|
6.33
|
1.24
|
%
|
$
|
21,307
|
||||||||||||||||||
| 11-20-2012 |
09-10-2019
|
20,000
|
$
|
3.56
|
$
|
3.50
|
41.45
|
%
|
6.50
|
1.24
|
%
|
$
|
20,664
|
||||||||||||||||||
| 02-14-2013 |
09-10-2019
|
20,000
|
$
|
3.67
|
$
|
3.50
|
41.45
|
%
|
6.45
|
1.24
|
%
|
20,140
|
|||||||||||||||||||
|
Description
|
Balance at Beginning of the Year
|
Charged to Costs and Expenses
|
Deductions
|
Balance at End of the Year
|
||||||||||||
|
Year ended March 31, 2013:
|
||||||||||||||||
|
Allowance for doubtful
Accounts
|
$
|
35,470
|
$
|
-
|
(16,530
|
)
|
$
|
18,940
|
||||||||
|
Allowance for obsolete
Inventory
|
$
|
200,000
|
$
|
-
|
$
|
-
|
$
|
200,000
|
||||||||
|
Year ended March 31, 2012:
|
||||||||||||||||
|
Allowance for doubtful
Accounts
|
$
|
36,670
|
$
|
-
|
(1,200
|
)
|
$
|
35,470
|
||||||||
|
Allowance for obsolete
Inventory
|
$
|
445,000
|
$
|
21,972
|
(266,972
|
) (1)
|
$
|
200,000
|
||||||||
|
Name (age)
|
Position
|
Year First
Elected a Director
|
||
|
Stephen A. Fletcher (1)
(52)
|
Director; General Manager of Kodak’s Digital Printers and Presses Strategic Group; General Manager of New Printing Technologies; Vice President of Consumer Digital Group since 2007
|
2011
|
||
|
George J. Leon (2) (3)
(69)
|
Director; Investment Manager and beneficiary of the George Leon Family Trust (Investments) since 1986.
|
1986
|
||
|
Jeffrey C. O’Hara, CPA (1)
(55)
|
Director; President since August 2007; Chief Executive Officer since December 2010; Chief Operating Officer since June 2006; Vice President since 2005
|
1998
|
||
|
Robert A. Rice (2) (3)
(57)
|
Director; President and Owner of Spurwink Cordage, Inc since1998 (textile manufacturing).
|
2004
|
||
|
Robert H. Walker (2) (3) (4)
(77)
|
Director and Chairman of the Board since April 2011; Retired Executive Vice President, Robotic Vision Systems, Inc. (design and manufacture of robotic vision systems) 1983-1998.
|
1984
|
|
(1)
|
Mr. Fletcher is the son of Mr. Harold K. Fletcher, the former Chairman of Tel-Instrument who passed away in April 2011, and the brother-in-law of Jeffrey C. O’Hara, the Company’s Chief Executive Officer
|
|
(2)
|
Member of the Audit Committee
|
|
(3)
|
Member of the Compensation Committee
|
|
(4)
|
Mr. Walker was elected Chairman of the Board in April 2011.
|
|
Name and Principal Position
|
Fiscal Year
|
Salary ($)
(1)
|
Incentive ($) (2)
|
Option Awards ($) (3)
|
All Other Compensation $ (4)
|
Total ($)
|
||||||||||||||||
|
Jeffrey C. O’Hara, CEO President (5)
|
2013
|
160,000
|
-
|
-
|
21,222
|
181,222
|
||||||||||||||||
|
2012
|
160,000
|
-
|
-
|
20,897
|
180,897
|
|||||||||||||||||
|
Joseph P. Macaluso
PAO
|
2013
|
110,000
|
-
|
-
|
6,471
|
116,471
|
||||||||||||||||
|
2012
|
106,346
|
-
|
8,648
|
7,503
|
122,497
|
|||||||||||||||||
|
(1)
|
The amounts shown in this column represent the dollar value of base cash salary earned by each named executive officer (“NEO”).
|
|
(2)
|
No incentive compensation was made to the NEO’s in 2013 and 2012, and therefore no amounts are shown.
|
|
(3)
|
Amounts in this column represent the fair value required by ASC Topic 718 to be included in our financial statements for all options granted during that year (see Note 14 to Notes to the Consolidated Financial Statements).
|
|
(4)
|
The amounts shown in this column represent amounts for medical and life insurance as well as the Company’s match in the 401(k) Plan.
|
|
(5)
|
On December 15, 2010, Mr. O’Hara became CEO.
|
|
Name
|
Number of Securities Underlying Unexercised Options (#)
Exercisable
|
Number of Securities Underlying Unexercised Options (#)
Unexercisable (1)
|
Option Exercise Price ($)
|
Option Expiration Date
|
|||||||||
|
Joseph P. Macaluso
|
800
|
3,200
|
$
|
6.59
|
12/14/16
|
||||||||
|
Jeffrey C. O’Hara
|
15,000
|
-
|
$
|
3.58
|
03/02/14
|
||||||||
|
3,000
|
2,000
|
$
|
8.00
|
02/22/15
|
|||||||||
|
6,000
|
9,000
|
$
|
7.62
|
12/15/15
|
|||||||||
|
(1)
|
Options are exercisable, on a cumulative basis, 20% at or after each of the first, second, and third anniversary of the grant and 40% after the fourth year anniversary.
|
|
Name
|
Number of shares acquired on exercise
|
Value realized on exercise (1)
|
||||||
|
Jeffrey C. O’Hara
|
5,000 | $ | (100 | ) | ||||
|
Name
|
Cash Compensation
|
Option Awards ($)(1)(2)
|
Total $
|
|||||||||
|
George J. Leon
|
$
|
16,250
|
$
|
-0-
|
$
|
16,250
|
||||||
|
Robert A. Rice
|
$
|
16,250
|
$
|
-0-
|
$
|
16,250
|
||||||
|
Robert H. Walker (3)
|
$
|
16,250
|
$
|
-0-
|
$
|
16,250
|
||||||
|
Stephen A. Fletcher
|
$
|
15,000
|
$
|
-0-
|
$
|
15,000
|
||||||
|
Name and Address
|
Number of Shares
Beneficially Owned
|
Percentage
of Class (1)
|
||||||
|
Named Directors and Officers
|
||||||||
|
Stephen A. Fletcher, Director
|
-0-
|
(2
|
)
|
0
|
%
|
|||
|
20 Windham Hill
|
||||||||
|
Mendon, NY 14506
|
||||||||
|
George J. Leon, Director
|
434,823
|
(3
|
)
|
13.5
|
%
|
|||
|
116 Glenview
|
||||||||
|
Toronto, Ontario, Canada M4R1P8
|
||||||||
|
Jeffrey C. O’Hara, Director
|
261,156
|
(4
|
)
|
8.1
|
%
|
|||
|
853 Turnbridge Circle
|
||||||||
|
Naperville, IL 60540
|
||||||||
|
Robert A. Rice, Director
|
116,504
|
(5
|
)
|
3.6
|
%
|
|||
|
5 Roundabout Lane
|
||||||||
|
Cape Elizabeth, ME 04107
|
||||||||
|
Robert H. Walker, Director
|
79,363
|
(6
|
)
|
2.5
|
%
|
|||
|
27 Vantage Court
|
||||||||
|
Port Jefferson, NY 11777
|
||||||||
|
Joseph P. Macaluso, PAO
|
24,313
|
(7
|
)
|
0.8
|
%
|
|||
|
167 Tennis Court
|
||||||||
|
Wall Township, NJ 07719
|
||||||||
|
All Officers and Directors as a Group (6 persons)
|
916,479
|
(8
|
)
|
28.0
|
%
|
|||
|
Mrs. Sadie Fletcher
|
656,907
|
(9
|
)
|
20.5
|
%
|
|||
|
657 Downing Lane
|
||||||||
|
Williamsville, NY 14221
|
||||||||
|
(1)
|
The class includes 3,211,739 shares outstanding in the calculation of the percentage of shares owned by a party. The common stock deemed to be owned by the named party, includes stock which is not outstanding but subject to currently exercisable options held by the individual named in accordance with Rule 13d-3(d)c) of the Exchange Act. The foregoing information is based on reports made by the named individuals.
|
|
(2)
|
Mr. Stephen A. Fletcher is the son of Mr. Harold K. Fletcher, former Chief Executive Officer and director of the Company. Mr. Stephen A. Fletcher is the son of Mrs. Sadie Fletcher who beneficially owns 656,907 shares by virtue of the Estate of Harold K. Fletcher. Mr. Fletcher disclaims beneficial ownership of the shares owned by the Estate of Harold K. Fletcher.
|
|
(3)
|
Includes 299,517 shares owned by the George Leon Family Trust, of which Mr. Leon is a beneficiary, and 10,200 shares subject to currently exercisable stock options. Mr. Leon acts as manager of the trust assets pursuant to an informal family, oral arrangement, and disclaims beneficial ownership of the shares owned by the trust.
|
|
(4)
|
Includes 24,000 shares subject to currently exercisable stock options owned by Mr. O’Hara.
|
|
(5)
|
Includes 10,700 shares subject to currently exercisable stock options owned by Mr. Rice.
|
|
(6)
|
Includes 10,700 shares subject to currently exercisable stock options owned by Mr. Walker.
|
|
(7)
|
Includes 800 shares subject to currently exercisable stock options owned by Mr. Macaluso.
|
|
(8)
|
Includes 56,400 shares subject to currently exercisable options held by all executive officers and directors of the Company (including those individually named above).
|
|
(9)
|
Represents 656,907 shares owned by the Estate of Harold K. Fletcher, former Chief Executive Officer and director of the Company. Mrs. Fletcher is the mother of Stephen A. Fletcher, a director of the Company.
|
|
Plan category
|
Number of securities to
be issued upon exercise of options
|
Weighted average
exercise price of options
|
Number of options remaining available for future issuance under Equity Compensation Plans
|
|||||||||
|
Equity Compensation Plans approved by shareholders *
|
114,600
|
$
|
5.53
|
218,978
|
||||||||
|
Equity Compensation Plans not approved by shareholders
|
--
|
--
|
--
|
|||||||||
|
Total
|
114,600
|
$
|
5.53
|
218,978
|
||||||||
|
2013
|
2012
|
|||||||
|
Audit Fees
|
$
|
117,500
|
$
|
117,500
|
||||
|
Audit-Related Fees
|
-
|
-
|
||||||
|
Total Audit and Audit-Related Fees
|
117,500
|
117,500
|
||||||
|
Tax Fees
|
-
|
-
|
||||||
|
All Other Fees
|
-
|
-
|
||||||
|
Total
|
$
|
117,500
|
$
|
117,500
|
||||
|
Pages
|
|
|
Financial Statements:
|
|
|
20
|
|
|
21
|
|
|
22
|
|
|
23
|
|
|
24
|
|
|
25-48
|
|
|
Financial Statement Schedule:
|
|
|
49
|
|
*
|
(3.1)
|
Tel-Instrument Electronics Corp's Certificate of Incorporation, as amended.
|
|
*
|
(3.2)
|
Tel-Instrument Electronics Corp's By-Laws, as amended.
|
|
*
|
(3.3)
|
Tel-Instrument Electronics Corp's Restated Certificate of Incorporation dated November 8, 1996.
|
|
*
|
(4.1)
|
Specimen of Tel-Instrument Electronics Corp's Common Stock Certificate.
|
|
*
|
(10.2)
|
10% convertible subordinated note between Registrant and Harold K. Fletcher.
|
|
*
|
(10.3)
|
Purchase agreement between Registrant and Innerspace Technology
|
|
*
|
(10.4)
|
Agreement between Registrant and Semaphore Capital Advisors, LLC
|
|
*
|
(10.5)
|
2006 Stock Option Plan
|
|
*
|
(10.6)
|
Subordinated Note Between Registrant and Harold K. Fletcher
|
|
*
|
(10.7)
|
Subordinated Note Between Registrant and Jeffrey C. O’Hara
|
|
*
|
(10.8)
|
Shareholder Purchase Agreement between the Registrant and Harold K. Fletcher
|
|
*
|
(10.9)
|
Shareholder Purchase Agreement between the Registrant and Jeffrey C. O’Hara
|
|
*
|
(10.10)
|
Shareholder Purchase Agreement between the Registrant and George Leon
|
|
*
|
(10.11)
|
Loan Agreement with BCA Mezzanine Fund, LLP and Amendments 1-3
|
|
*
|
(10.12)
|
Intercreditor and Subordination Agreement among Harold. K. Fletcher, Jeffrey C. O’Hara and BCA Mezzanine Fund, LLP.
|
|
*
|
(10.13)
|
Subscription Agreement between Registrant and Subscriber, dated November 8, 2012
|
|
(23.1)
|
||
|
(31.1)
|
||
|
(31.2)
|
||
|
(32.1)
|
||
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
Taxonomy Extension Schema Document
|
|
| 101.CAL |
Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF
|
Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB
|
Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE
|
Taxonomy Extension Presentation Linkbase Document
|
|
|
*
|
Incorporated by reference to previously filed documents.
|
|
|
The Company will furnish to a stockholder, upon request, any exhibit at cost.
|
|
TEL-INSTRUMENT ELECTRONICS CORP
|
|||
|
(Registrant)
|
|||
|
Dated: July 16, 2013
|
By:
|
/s/ Jeffrey C. O’Hara
|
|
|
Jeffrey C. O’Hara
|
|||
|
CEO and Director
|
|||
|
(Principal Executive Officer)
|
|||
|
Signature
|
Title
|
Date
|
|||
|
/s/ Jeffrey C. O’Hara
|
CEO, President, COO and Director
|
July 16, 2013
|
|||
|
Jeffrey C. O’Hara
|
|||||
|
/s/ Joseph P. Macaluso
|
Principal Accounting Officer
|
July 16, 2013
|
|||
|
Joseph P. Macaluso
|
|||||
|
/s/ Stephen A. Fletcher
|
Director
|
July 16, 2013
|
|||
|
Stephen A. Fletcher
|
|||||
|
/s/ George J. Leon
|
Director
|
July 16, 2013
|
|||
|
George J. Leon
|
|||||
|
/s/ Robert A. Rice
|
Director
|
July 16, 2013
|
|||
|
Robert A. Rice
|
|||||
|
/s/ Robert H. Walker
|
Chairman of the Board, Director
|
July 16, 2013
|
|||
|
Robert H. Walker
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|